To further explore the role of NF-κB on sudemycin activity, we stimulated the NF-κB pathway in CLL cells with CD40 ligand (CD40L) and interleukin 4 (IL4) soluble factors. Here, NFKB1 is linked to B-cell chronic lymphocytic leukemia.